Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-03 · accession 0001140361-25-041393 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 2025-11-03 | RCKT | Wilson Martin | GC | A - Grant | $0.00 | +100.0K | 385.5K | +35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | A | A | 100,000 | $0.00 | 385,462 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |